Skip to content
SH

Sangam Health Care Products

531625 BSE
Price unavailable
View as Markdown
MCP

No trades in 1Y

Peer Comparison

Healthcare › Healthcare Equipment & Supplies › Medical Equipment & Supplies

Sangam Health Care Products peer comparison
Molbio Diagnostics
₹1,381.80123.38₹15,607 Cr11.630.00%13.80%18.00%₹1,077 Cr₹125 Cr
Poly Medicure
₹1,586.8051.04₹15,325 Cr5.180.23%9.02%12.50%₹1,997 Cr₹313 Cr
Fischer Medical Ventures
₹25.2366.39₹1,611 Cr3.610.20%8.91%11.40%₹367 Cr₹24 Cr
Tarsons Products
₹311.10148.85₹1,603 Cr2.610.67%2.44%4.59%₹441 Cr₹11 Cr
Q-Line Biotech
₹527.1524.98₹1,243 Cr2.520.00%26.00%22.40%₹201 Cr₹34 Cr
Laxmi Dental
₹188.7133.64₹1,017 Cr4.270.00%14.80%15.00%₹287 Cr₹31 Cr
Hemant Surgical Industries
₹608.10—₹868 Cr5.640.00%16.90%18.90%——
Sangam Health Care Products (this company)
——————10.50%₹11 Cr₹0 Cr
Median 8 companies₹527.1558.72₹1,603 Cr4.270.00%13.80%13.75%₹367 Cr₹31 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Key Insights

No strengths listed

Weaknesses

2
  • The company has delivered a poor sales growth of 3.32% over past five years.
  • Debtor days have increased from 76.2 to 114 days.

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y−7.20%
5Y+3.32%
3Y+1.44%
1Y−9.87%
TTM−3.70%

Net profit

Net profit growth by window
10YTurned to profit
5YTurned to profit
3YTurned to profit
1Y−88.89%
TTM−2.13%

Operating cash flow

Operating cash flow growth by window
10YTurned positive
5Y−26.52%
3Y−77.08%
1YTurned positive
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y−12.62 pp
5Y+16.07 pp
3Y+3.35 pp
1Y−9.49 pp
TTM−5.20 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹24.16 Cr
Mar 2018₹20.99 Cr
Mar 2019₹21.04 Cr
Mar 2020₹21.81 Cr
Mar 2021₹9.54 Cr
Mar 2022₹8.70 Cr
Mar 2023₹10.76 Cr
Mar 2024₹12.11 Cr
Mar 2025₹12.46 Cr
Mar 2026₹11.23 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017−₹6.86 Cr
Mar 2018₹7.37 Cr
Mar 2019−₹2.03 Cr
Mar 2020₹4.05 Cr
Mar 2021−₹2.30 Cr
Mar 2022−₹1.55 Cr
Mar 2023−₹1.16 Cr
Mar 2024₹0.42 Cr
Mar 2025₹0.45 Cr
Mar 2026₹0.05 Cr

Quarterly Results

₹ Cr
531625 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
2.56
3.05
3.53
2.97
3.39
3.62
2.87
2.58
2.82
3.04
2.72
2.66
3.03
Expenses
2.94
2.54
2.66
2.79
3
3.24
2.46
2.29
2.7
2.74
2.42
3.14
2.59
Operating Profit
−0.38
0.51
0.87
0.18
0.39
0.38
0.41
0.29
0.12
0.3
0.3
−0.48
0.44
OPM %
−14.84%
16.72%
24.65%
6.06%
11.5%
10.5%
14.29%
11.24%
4.26%
9.87%
11.03%
−18.05%
14.52%
Other Income
0
0
0
0
0
0
0
0.02
0
0
0
0.02
0
Interest
0.01
0
0.01
0.01
0
0
0
0.01
0
0
0
0
0
Depreciation
0.3
0.3
0.3
0.31
0.3
0.3
0.3
0.31
0.01
0.01
0.01
0.02
0.01
PBT
−0.69
0.21
0.56
−0.14
0.09
0.08
0.11
−0.01
0.11
0.29
0.29
−0.48
0.43
Tax %
0%
0%
0%
0%
0%
0%
0%
−1900%
9.09%
17.24%
34.48%
−39.58%
27.91%
Net Profit
−0.69
0.2
0.56
−0.14
0.08
0.07
0.11
0.19
0.1
0.23
0.2
−0.28
0.31
EPS (₹)
−0.46
0.13
0.38
−0.09
0.05
0.05
0.07
0.13
0.07
0.15
0.13
−0.19
0.21

Profit & Loss

₹ Cr
531625 profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
25.44
23.71
24.16
20.99
21.04
21.81
9.54
8.7
10.76
12.11
12.46
11.23
11.45
Expenses
21.43
20.19
24.55
25.62
20.09
19.78
10.86
9.1
10.88
10.67
11
10.98
10.89
Operating Profit
4.01
3.52
−0.39
−4.63
0.95
2.03
−1.32
−0.4
−0.12
1.44
1.46
0.25
0.56
OPM %
15.76%
14.85%
−1.61%
−22.06%
4.52%
9.31%
−13.84%
−4.6%
−1.12%
11.89%
11.72%
2.23%
4.89%
Other Income
4.75
0.27
0.12
18.41
0.47
2.93
0.02
0
0
0
0.02
0.02
0.02
Interest
5.46
3.8
5.05
3.33
2.1
0.29
0.07
0.11
0.03
0.02
0.01
0.01
0
Depreciation
1.51
1.53
1.52
1.52
1.5
1.26
1.22
1.22
1.22
1.22
1.22
0.06
0.05
PBT
1.79
−1.54
−6.84
8.93
−2.18
3.41
−2.59
−1.73
−1.37
0.2
0.25
0.2
0.53
Tax %
0%
0%
0.29%
17.36%
−6.88%
−18.77%
−11.2%
−10.4%
−14.6%
−110%
−76%
75%
—
Net Profit
1.79
−1.54
−6.86
7.37
−2.03
4.05
−2.3
−1.55
−1.16
0.42
0.45
0.05
0.46
EPS (₹)
1.2
−1.04
−4.62
4.96
−1.37
2.73
−1.55
−1.04
−0.78
0.28
0.3
0.03
0.3
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
531625 balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
14.86
14.86
14.86
14.86
14.86
14.86
14.86
14.86
14.86
14.86
14.86
14.86
Reserves
−31.81
−33.35
−37.85
−28.59
−34.83
−30.78
−33.08
−34.63
−35.79
−35.37
−34.92
−34.71
Borrowings
35.37
36.08
37.27
17.25
21.15
17.59
18.21
23.4
21.08
19.34
21.98
21.93
Other Liabilities
14.15
15.13
13.65
18.66
22.59
11.29
9.43
5.46
7.92
7.67
9.42
9.14
Total Liabilities
32.57
32.72
27.93
22.18
23.77
12.96
9.42
9.09
8.07
6.5
11.34
11.22
Fixed Assets
23.94
22.63
21.44
19.93
18.65
6.24
5.02
3.81
2.61
1.39
0.18
0.3
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
8.63
10.09
6.49
2.25
5.12
6.72
4.4
5.28
5.46
5.11
11.16
10.92
Total Assets
32.57
32.72
27.93
22.18
23.77
12.96
9.42
9.09
8.07
6.5
11.34
11.22

Cash Flow

₹ Cr
531625 cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
−16.8
−0.37
−4.44
−5.97
11.05
−11.08
0.14
0.99
2.49
1.94
−2.76
0.03
Investing
4.71
−0.21
−0.29
18.7
−1.02
11.18
0.02
0.02
0
0
0
−0.02
Financing
12.22
2.07
3.13
−12.72
−10.15
−0.02
−0.13
−0.13
−2.35
−1.77
2.63
−0.06
Net Cash Flow
0.13
1.48
−1.6
0.01
−0.12
0.07
0.03
0.88
0.14
0.18
−0.13
−0.06
Free Cash Flow
−16.84
−0.58
−4.78
−5.98
10.82
0.08
0.14
0.99
2.49
1.94
−2.76
0.03
CFO/OP
−419
−11
1,138
129
1,171
−546
−11
−248
−2,075
135
−189
12

Ratios

531625 financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
3.73
2
0.91
0.17
6.07
8.37
26.4
25.59
21.37
8.14
106
114
Inventory Days
327
257
136
21.81
107
137
68.48
133
162
101
90.56
78.77
Days Payable
259
286
156
127
155
219
285
191
384
359
455
480
Cash Conversion Cycle
71.32
−26.94
−19.07
−106
−41.64
−73.53
−190
−32.73
−201
−250
−258
−286
Working Capital Days
−225
−240
−254
−339
−628
−346
−880
−981
−107
−110
−77.92
−75.41
ROCE %
37.12%
12.55%
−11.23%
137.75%
−3.4%
259.65%
−303.61%
−89.5%
−70.9%
—
69.33%
10.5%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Sangam Health Care Products insights

29 extracted metrics across FY15–FY27.

Shareholding Pattern

As of Jun 2026

  • Promoters 70.12%
  • Public 21.44%
  • DIIs 8.43%

Pledge data not available

Change since Mar 2026

Documents

Frequently Asked Questions about Sangam Health Care Products

What does Sangam Health Care Products Ltd do?
Sangam Health Care Products is engaged manufacturing and trading of medical products
Where is Sangam Health Care Products Ltd (SANHP) listed?
Sangam Health Care Products Ltd trades under code 531625 on the BSE.
Which sector does Sangam Health Care Products Ltd belong to?
Sangam Health Care Products Ltd is classified under the Healthcare sector, in the Healthcare Equipment & Supplies industry.

Company Information

Sangam Health Care Products is engaged manufacturing and trading of medical products

Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/531625.md for Sangam Health Care Products Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Healthcare Equipment stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month